Doctor Care Anywhere Group PLC (ASX: DOC) Share Price and News
Price
–
Movement
– ( )
(20 mins delayed)
52 Week Range
– - –
1 Year Return
Doctor Care Anywhere Group PLC Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
–
Day Change
– ( )
52 Week Range
– - –
Yesterday's Close
–
Today's Open
–
Days Range
– - –
Volume
–
Avg. Volume (1 month)
–
Turnover
–
Doctor Care Anywhere Group PLC (ASX: DOC)
Latest News

Small Cap Shares
2 quality small cap ASX shares rated as buys

Small Cap Shares
3 exciting small cap ASX shares to watch

Share Market News
Airtasker (ASX:ART) share price cools after explosive IPO

Small Cap Shares
3 small cap ASX shares rated as buys

Share Gainers
Why the Doctor Care Anywhere (ASX:DOC) share price is up 62% since December
Speculative
2 exciting small cap ASX shares to watch

Share Market News
Here's why the Doctor Care Anywhere (ASX:DOC) share price gained 57% in two months
ASX Shares
Here are 3 ASX IPOs this fund manager was buying

Share Gainers
Why the Doctor Care Anywhere (ASX:DOC) share price is shooting 6% higher

Share Gainers
Why the Doctor Care Anywhere (ASX:DOC) share price surged to a record high
ASX Shares
2 newly listed ASX shares to watch in 2021

Share Gainers
Why a2 Milk, Doctor Care Anywhere, McPherson's, & Volpara are pushing higher
DOC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|
About Doctor Care Anywhere Group PLC
Doctor Care Anywhere Group PLC is a telehealth company that provides clinical care through digitally enabled, joined-up, evidence-based pathways on its proprietary platform. It utilizes its relationships with health insurers, healthcare providers, and corporate customers to connect with patients to deliver a range of telehealth services. The Group provides virtual healthcare services, technology platform licensing, and digital design services, within the United Kingdom, Australia, and the Republic of Ireland. The company derives a majority of its revenue from the UK and Ireland.
DOC Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
19 May 2025 | $0.10 | $0.00 | 0.00% | 336,091 | $0.10 | $0.11 | $0.10 |
16 May 2025 | $0.10 | $0.00 | 0.00% | 70,319 | $0.10 | $0.10 | $0.10 |
15 May 2025 | $0.10 | $0.00 | 0.00% | 300,589 | $0.09 | $0.10 | $0.09 |
14 May 2025 | $0.10 | $0.00 | 0.00% | 158,338 | $0.09 | $0.10 | $0.09 |
13 May 2025 | $0.09 | $0.01 | 11.49% | 347,066 | $0.09 | $0.09 | $0.09 |
12 May 2025 | $0.09 | $0.00 | 0.00% | 431,723 | $0.09 | $0.09 | $0.09 |
09 May 2025 | $0.09 | $0.00 | 0.00% | 193,319 | $0.08 | $0.09 | $0.08 |
08 May 2025 | $0.08 | $0.00 | 0.00% | 67,474 | $0.08 | $0.08 | $0.08 |
07 May 2025 | $0.08 | $0.00 | 0.00% | 349,820 | $0.09 | $0.09 | $0.08 |
06 May 2025 | $0.09 | $0.00 | 0.00% | 38,660 | $0.08 | $0.09 | $0.08 |
05 May 2025 | $0.08 | $0.00 | 0.00% | 250,248 | $0.08 | $0.09 | $0.08 |
02 May 2025 | $0.08 | $0.00 | 0.00% | 112,475 | $0.08 | $0.09 | $0.08 |
01 May 2025 | $0.09 | $0.01 | 12.50% | 235,613 | $0.08 | $0.09 | $0.08 |
30 Apr 2025 | $0.08 | $0.00 | 0.00% | 192,526 | $0.08 | $0.08 | $0.08 |
29 Apr 2025 | $0.08 | $0.00 | 0.00% | 200,000 | $0.08 | $0.08 | $0.08 |
28 Apr 2025 | $0.08 | $0.00 | 0.00% | 188,064 | $0.08 | $0.08 | $0.08 |
24 Apr 2025 | $0.08 | $0.00 | 0.00% | 86,698 | $0.08 | $0.08 | $0.08 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
07 May 2025 | John Stier | Buy | 500,000 | $41,760 |
On-market trade. average
|
31 Mar 2025 | Laura O Riordan | Buy | 500,000 | $47,734 |
On-market trade.
|
30 Dec 2024 | Ben Kent | Buy | 55,000 | $4,295 |
On-market trade.
|
24 Dec 2024 | Ben Kent | Buy | 305,000 | $23,202 |
On-market trade.
|
20 Dec 2024 | John Stier | Buy | 500,000 | $35,500 |
On-market trade.
|
18 Dec 2024 | Ben Kent | Buy | 320,000 | $22,010 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr David Ravech | Non-Executive Director | Apr 2015 |
Mr Ravech is a co-founder and former CEO of Doctor Care Anywhere Group plc which is the provider of private primary online care consultations in the UK. David also co-founded and chairs Rapid Health, which is the leading autonomous triage technology provider to NHS primary care organisations. Since 1998, David has led and invested in building disruptive technology companies from whiteboard etchings to reality. Prior to co-founding Doctor Care Anywhere, David was the founder and CEO of Overland Health, a technology-driven provider of rehabilitation services. He also founded Co-CEO Global Freight Exchange (GF-X) in 1998 which provided the world's leading airlines and freight forwarders with the first online price and availability comparison engine and transaction system for airfreight. David initially qualified as a barrister and solicitor with Arthur Robinson & Hedderwicks (now Allens), working in the Securities, Mergers and Acquisitions group. He then spent six years as a strategy management consultant at McKinsey, based in the Melbourne and London offices. He worked in Australia, the UK, Japan, Israel and several European countries, primarily serving clients in the retail, brewing, telecoms, medical device and banking sectors with a focus on mergers and acquisitions, competition law approvals and pricing strategy.
|
Mr John Robert Stier | Non-Executive ChairmanNon-Executive Director | May 2022 |
Mr Stier brings experience in change management, M&A, and scaling businesses plus financial expertise gained in services-based industries. John built an executive career as a financial professional, becoming Group CFO of two technology enabled services businesses Northgate Information Solutions Plc and Equiniti Plc. Northgate provides technology and outsourced solutions to the UK Government and global HR market, Equiniti is an international share registrar. John worked with these businesses for over twenty years, helping to build them both into FTSE 250 constituents on the London Stock Exchange. John is also currently the Chair at Shift.MS, a digital charity for MS sufferers; Chair of the Audit and Finance Change Committee and a Board member at Proactis, a SAS procurement business; and Chair of the Audit and Finance Change Committee and a Board member at Keywords Studios, a global gaming firm.
|
Mr Matthew Addison | Non-Executive Director | Oct 2024 |
Mr Addison previously advised the Company in relation to the refinancing of existing debt through the issue of its convertible loan note in late 2023 and early 2024, placing it in a more sustainable position for future growth. He holds options in the Company connected with this work and consequently is not considered to be independent under the ASX Corporate Governance Council's Principles. However, the Board considers that he exercises independent judgement in relation to Board and Committee matters. He is both a repeat technology company founder and an investor. He is CEO of FinTech Step Ladder Solutions Ltd, founded in 2016 with backing from blue-chip growth investors including BBVA, Anthemis, Seedcamp and UK Future Fund. Prior to founding StepLadder, Matthew had a 15-year career in investment management with hedge funds Och-Ziff, Cheyne Capital, JCAM (formerly Moore Credit Fund) and Platinum Capital Management during which time he participated in several boards of portfolio companies undertaking recapitalizations, listings and M&A exits. He has experience of advising and managing companies and businesses in periods of strategic change.
|
Ms Laura O Riordan | Chief Executive OfficerExecutive Director | Jan 2025 |
Ms ORiordan has latest role as President at eMed Healthcare UK (formally Babylon). Laura brings a wealth of leadership and digital healthcare knowledge from her previous roles at Babylon, The Good Care Group, Care UK and Harmoni.
|
Professor Sam Shah | Non-Executive Director | Jan 2025 |
Prof Shah is a public health consultant and specialist in dental public health, in epidemiology, health regulation and corporate governance. He holds both clinical and legal qualifications and co-founded East Village Clinic Group, an NHS and private healthcare services organisation. Professor Shah is Director of SAS Consultancy Services Limited (The Ivory Clinic) and EVD Group Holdings Limited (East Village Dental) and their respective subsidiaries. He is also a Non-Executive Director of the Private Healthcare Information Network, Director and advisor of Quiddity and Director of Health Data Management, NEOM. He has knowledge across the technology, investment, and global health ecosystem; having worked with organisations across Europe, North America, Middle East and Asia.
|
Ms Cathy Baxandall | Company Secretary | Feb 2024 |
-
|
Ben Kent | Chief Executive Officer |
-
|
|
Seema Sangar | Chief Financial Officer |
-
|
|
Cathy Baxandall | Company Secretary |
-
|
|
James Warren | Group Finance Director |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
UBS Nominees Pty Ltd | 96,370,683 | 26.29% |
Carani Holdings Limited | 44,264,604 | 12.07% |
Vijay Patel | 26,094,880 | 7.12% |
BGF Nominees Limited <Bgf Investments Lp A/C> | 18,042,248 | 4.92% |
Buttonwood Nominees Pty Ltd | 16,464,182 | 4.49% |
Bhikhu Patel | 8,698,178 | 2.37% |
Patagorang Pty Ltd <Roger Allen Family A/C> | 8,191,201 | 2.23% |
Gleneagle Securities Nominees Pty Limited | 6,497,000 | 1.77% |
Lawn Views Pty Ltd <Angela Williams Family A/C> | 6,000,000 | 1.64% |
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> | 5,062,389 | 1.38% |
Hadston 1 Llp\C | 4,829,815 | 1.32% |
Jasforce Pty Ltd | 4,319,949 | 1.18% |
Mr Cornelius Donovan | 3,757,958 | 1.03% |
BGF Nominees Limited <Bgf Ventures Lp A/C> | 3,742,855 | 1.02% |
Indigenous Capital Limited | 3,116,420 | 0.85% |
Spinite Pty Ltd | 2,798,650 | 0.76% |
Mr Kenneth Joseph Hall <Hall Park A/C> | 2,500,000 | 0.68% |
Barnett Waddingham Trustees (1996) Limited <Anthony | 2,406,855 | 0.66% |
Barnett Waddingham Trustees (1996) Limited <Hrmp Directors P/Sch A/C> | 2,406,855 | 0.66% |
Barnett Waddingham Trustees (1996) Limited <Mj Rutherford Ltd D/Pf A/C> | 2,406,855 | 0.66% |